{"id":"https://openalex.org/W95586784","doi":null,"title":"Bispecific antibody therapy of two murine B-cell lymphomas.","display_name":"Bispecific antibody therapy of two murine B-cell lymphomas.","publication_year":1992,"publication_date":"1992-01-01","ids":{"openalex":"https://openalex.org/W95586784","mag":"95586784","pmid":"https://pubmed.ncbi.nlm.nih.gov/1428409"},"language":"en","primary_location":{"id":"pmid:1428409","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1428409","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer. Supplement = Journal international du cancer. Supplement","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111602533","display_name":"C. Demanet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I13469542","display_name":"Vrije Universiteit Brussel","ror":"https://ror.org/006e5kg04","country_code":"BE","type":"education","lineage":["https://openalex.org/I13469542"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"C Demanet","raw_affiliation_strings":["Unit of Hematology-Immunology, Vrije Universiteit Brussel (VUB), Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Unit of Hematology-Immunology, Vrije Universiteit Brussel (VUB), Belgium","institution_ids":["https://openalex.org/I13469542"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109286708","display_name":"Jan Brissinck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Brissinck","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036848403","display_name":"Muriel Moser","orcid":"https://orcid.org/0000-0002-5269-1283","observed_orcids":["https://orcid.org/0000-0002-5269-1283"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M Moser","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030183502","display_name":"Oberdan L\u00e9o","orcid":"https://orcid.org/0000-0002-3621-4743","observed_orcids":["https://orcid.org/0000-0002-3621-4743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"O Leo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5111500363","display_name":"Kristiaan Thielemans","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"K Thielemans","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3014,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.48642099,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"7","issue":null,"first_page":"67","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8353999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.8353999853134155,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.1429000049829483,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.00930000003427267,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.996999979019165},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.9240000247955322},{"id":"https://openalex.org/keywords/idiotype","display_name":"idiotype","score":0.45899999141693115},{"id":"https://openalex.org/keywords/cd3","display_name":"CD3","score":0.7039999961853027},{"id":"https://openalex.org/keywords/t-cell-redirection","display_name":"T cell redirection","score":0.7990000247955322},{"id":"https://openalex.org/keywords/t-cell-mediated-lysis","display_name":"T cell-mediated lysis","score":0.6100000143051147},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.7099999785423279},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6069999933242798},{"id":"https://openalex.org/keywords/hybridoma-cells","display_name":"hybridoma","score":0.6010000109672546},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.5889999866485596},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-bearing-mice","display_name":"tumor-bearing mice","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C74505204","wikidata":"https://www.wikidata.org/wiki/Q1047644","display_name":"Idiotype","level":4,"score":0.5919837951660156},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5548490285873413},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.5440858602523804},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.4989607334136963},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4773540496826172},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.45754098892211914},{"id":"https://openalex.org/C956191","wikidata":"https://www.wikidata.org/wiki/Q930144","display_name":"Polyclonal antibodies","level":3,"score":0.4408456087112427},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.4370631277561188},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.43051978945732117},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4259698987007141},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4120534360408783},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3189687132835388},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.25528475642204285}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003602","descriptor_name":"Cytotoxicity, Immunologic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004797","descriptor_name":"Enzyme-Linked Immunosorbent Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008809","descriptor_name":"Mice, Inbred C3H","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016393","descriptor_name":"Lymphoma, B-Cell","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"pmid:1428409","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1428409","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"International journal of cancer. Supplement = Journal international du cancer. Supplement","raw_type":"Journal Article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/57266","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/57266","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"International journal of cancer. Supplement, 7","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:vubissmart:VUBISSMART:2000:10025","doi":null,"is_oa":false,"landing_page_url":"https://biblio.vub.ac.be/vubir/bispecific-antibody-therapy-of-two-murine-bcell-lymphomas(7c11daa9-a63d-455c-930f-21fc408543e5).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306402573","display_name":"VUBIR (Vrije Universiteit Brussel)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I13469542","host_organization_name":"Vrije Universiteit Brussel","host_organization_lineage":["https://openalex.org/I13469542"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"},{"id":"mag:95586784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/1428409","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1902787731","https://openalex.org/W1509169190","https://openalex.org/W2401939850","https://openalex.org/W2037385111","https://openalex.org/W2248997616","https://openalex.org/W1493845674","https://openalex.org/W2125603182","https://openalex.org/W304755779","https://openalex.org/W267542028","https://openalex.org/W2325130087"],"abstract_inverted_index":{"Numerous":[0],"in":[1,118,131],"vitro":[2],"studies":[3],"have":[4,33],"shown":[5],"that":[6,100,111,121],"T":[7,74,84,105,123],"lymphocytes":[8],"can":[9],"be":[10,66],"targeted":[11],"towards":[12,107],"any":[13],"target":[14,29,92,104],"cell":[15,30,46,75,114,124],"by":[16,68,82],"using":[17],"bispecific":[18],"antibodies":[19,63],"(bsAbs)":[20],"with":[21],"specificity":[22,57],"of":[23,42,58,73,79,89,95,136],"the":[24,38,43,59,71,77,90,108,137],"CD3/TCR":[25],"complex":[26],"and":[27,49,51,86,120,134],"a":[28],"antigen.":[31],"We":[32],"produced":[34,61],"bsAbs":[35,101],"directed":[36],"against":[37],"membrane":[39],"expressed":[40],"idiotype":[41],"murine":[44,52],"B":[45],"lymphomas":[47],"BCLI":[48],"38C13,":[50],"CD3":[53],"complex.":[54],"The":[55],"dual":[56],"hybrid-hybridoma":[60],"monoclonal":[62],"(MAbs)":[64],"could":[65,102],"demonstrated":[67,99],"flow":[69],"cytometry,":[70],"induction":[72,78],"proliferation,":[76],"IL2":[80],"secretion":[81],"polyclonal":[83],"cells,":[85,110],"redirected":[87],"lysis":[88],"relevant":[91],"cells.":[93],"Immunotherapy":[94],"tumor":[96,109,112,128],"bearing":[97],"animals":[98],"efficiently":[103],"cells":[106],"cell--T":[113],"bridging":[115],"is":[116],"established":[117],"vivo,":[119],"both":[122],"subsets":[125],"contribute":[126],"to":[127],"regression":[129],"resulting":[130],"long-term":[132],"survival":[133],"cure":[135],"lymphomas.":[138]},"counts_by_year":[],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}